Wolf Greenfield announced that Michael J T. has joined the firm as a shareholder. A skilled counselor to biotechnology and life sciences companies, Michael brings extensive experience in patent prosecution and portfolio development, patent licensing, and post-grant proceedings. He is skilled in the negotiation of patent licenses and the conduct of IP due diligence analyses in connection with mergers, acquisitions, public offerings and venture capital financings.
In addition, Michael has experience in U.S. Patent Office post-grant proceedings, including inter partes reviews (IPRs), inter partes reexams and ex parte reexams; appeals before the U.S. Board of Patent Appeals and Interferences, and the Court of Appeals for the Federal Circuit; oppositions before the European Patent Office; and U.S. district court patent litigation.
Michael was recommended in the 2016 edition of The Legal 500 United States for intellectual property: patents, portfolio management and licensing, and was recognized as a “Life Sciences Star” for outstanding intellectual property work in the 2012-2016 editions of LMG Life Sciences. He previously served as a partner at the law firm WilmerHale after beginning his career as an associate at Wolf Greenfield.
“Michael has broad knowledge of life sciences companies, from startups to multinational corporations,” said John Van Amsterdam, chair of Wolf Greenfield’s Biotechnology Group. “He knows how to let business needs guide intellectual property strategy, which is a longstanding focus for our firm.”
“Michael has broad knowledge of life sciences companies, from startups to multinational corporations,” said John Van Amsterdam, chair of Wolf Greenfield’s Biotechnology Group. “He knows how to let business needs guide intellectual property strategy, which is a longstanding focus for our firm.”
